[Pulmonary infections in children. II - Mycoplasma pneumonia].
The authors show a literary review on Mycoplasma pneumonia which represents a fifth of human pneumonia. M. pneumoniae is the major cause of illness in school-age children (5-9 years) and young adults and the peak incidence of illness occurs in this age. The infection appears mainly as an interstitial pneumonitis and the onset of illness is gradual, influence-like with few clinical symptoms and typical roentgenographic and bronchoscopic findings. Cold hemagglutinins appear in approximately 50% of patients. A severe prognosis can be associated with extrarespiratory symptoms; Erythromycin (as others macrolides) is the drug of choice.
Della Santa
L
L
Istituto di Clinica Pediatrica, Università degli Studi di Pisa.
Crimaldi
G
G
Pellegrini
V
V
Migliaccio
P
P
Pampana
A
A
D000367:Age Factors; D001927:Brain Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D009177:Mycoplasma pneumoniae / Q000472:pathogenicity*; D011019:Pneumonia, Mycoplasma / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D011379:Prognosis; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D012621:Seasons; D012871:Skin Diseases / Q000209:etiology
D004917:Erythromycin; D012293:Rifampin
Infezioni polmonari emergenti nel bambino. II--Polmoniti da micoplasmi.